Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study

✍ Scribed by Rothenberg, M. L.; Cox, J. V.; Butts, C.; Navarro, M.; Bang, Y.-J.; Goel, R.; Gollins, S.; Siu, L. L.; Laguerre, S.; Cunningham, D.

• Book ID: 126623916
• Publisher: Oxford University Press
• Year: 2008
• Tongue: English
• Weight: 149 KB
• Volume: 19
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdn370